Research

Surgical Site Infection Following Open Posterior Spine Surgery: Which is the Most Affected?

10.4274/BTDMJB.20171114065534

  • Azharuddin Azharuddin
  • Harapan Harapan
  • Jonny Karunia Fajar

Received Date: 14.11.2017 Accepted Date: 17.04.2018 Med J Bakirkoy 2018;14(4):389-393

Objective:

Surgical site infection (SSI) is an important cause of surgical wound healing disorders. Although SSI is uncommon in open posterior spine surgery, it is potentially correlated with serious morbidity, increased resource utilization and mortality. To evaluate the association between several spinal disorders treated with open posterior spine surgery and the risk of SSI.

Materials and Methods:

A retrospective study was conducted in Dr. Zainoel Abidin General Hospital included data during January 2012 to December 2015. The data of the spinal disorders treated with open posterior spine surgery and the risk of SSI were extracted from medical record. A chi-square was employed to assess the association between spinal disorders treated with open posterior spine surgery and the incidence of SSI.

Results:

A total of seven (2.4%) SSIs of 289 patients treated with open posterior spine surgery were analyzed. Spinal tuberculosis was associated with 5.9 fold increased the risk of SSI [odds ratio 95% confidence interval= 5.99 (1.14-31.51), p=0.034]. While, other spinal disorders including spinal stenosis (p=0.311), spine fracture (p=0.759), herniated nucleus pulposus (p=0.484), spinal dislocations (p=0.806), spondylolisthesis (p=0.925), spinal tumor (p=0.491), and scoliosis (p=0.707) had no significant association with the risk of SSI.

Conclusion:

In our population, spinal tuberculosis is indicated to be correlated with the risk of SSI.

Keywords: Surgical site infection, open posterior spine surgery, spinal disorders, spinal tuberculosis, risk factor

INTRODUCTION

Surgical site infection (SSI), formerly called surgical wound infections (1), are infections occurring up to 30 days after surgery (or up to one year after surgery in patients receiving implants) and affecting either the incision or deep tissue at the operation site (2,3). However, the widely used SSI definition refers to the SSI classification consisting of superficial incisional, deep incisional, and organ/space SSI (4). The incidence of SSI in all cases of surgery is vary, ranging from 0.8% in US to 16.4% in Japan (3) and for spinal surgery is ranging from 0.22% to 9.4% (5-10). SSIs were associated with an increased in treatment costs about more than fourfold (11) or US$ 15,800 to 43,900 per admission (12) or US$ 10 billion per year (3) due to prolonged hospitalization, additional diagnostic tests, therapeutic antibiotic treatment, and additional surgery procedures (4,8). In addition, studies also found that SSI was associated with an increased mortality rate, which was most often due to Staphylococcus aureus infection (13-15). Because SSIs are associated with a fatal consequence, efforts to reduce SSI are paramount and it is necessary to take precautions by being aware to several factors that have the potential to induced SSI.

SSI in spinal surgery can be superficial (above the fascia) or deep (below the fascia) such as spondylitis, discitis, spondylodiscitis, and epidural abscess (16). The incidence of SSIs in spinal surgery is rare, compared with other types of surgery (3). Although its incidence in spinal surgery is relatively infrequent event, SSIs are proven to be correlated with a high morbidity, mortality, increased additional cost and resource utilization (1). In addition, studies revealed that SSIs are also correlated with a long duration of surgery usually longer than three hours (17,18). Given the fact that the mean surgical time for spinal disorder is about four hours (19), therefore SSIs are potentially acquired among spinal disorder surgical procedures. Here, we reported the incidence of SSIs in patients with spinal disorders treated with open posterior spine surgery. The data are expected to be a clue for physicians to concern about several cases that have the potency for the risk of SSIs.


MATERIALS AND METHODS


Study Designs and Participants

This is a single-center retrospective study conducted in Dr. Zainoel Abidin General Hospital. The total population was all spinal disorder patients underwent open posterior spine surgery (289 patients - updated January 9th 2016) treated in Dr. Zainoel Abidin General Hospital during January 2012 to December 2015. A total sampling method was used in the study and 289 cases were identified.


Eligibility Criteria and Measures

Eligibility criteria consisted of predefined inclusion and exclusion criteria. Inclusion criteria for this study were (1) patients with spinal disorders treated with open posterior spine surgery (2) patients with SSI after open posterior spine surgery. The exclusion criteria in this study were incomplete medical record. Demographic and clinical data of the patients were retrieved from medical record. The explanatory variable in this study was spinal disorders while the response variable was the risk of SSI, which is defined as infections occurring up to 30 days after surgery and affecting either the incision or deep tissue at the operation site (2).


Statistical Analysis

Data of odds ratio (OR) and 95% confidence interval (95% CI) regarding the association between spinal disorders and the risk of SSI were analyzed using chi-square test with SPSS software. The value of p<0.05 was considered statistically significant.


RESULTS

Over the study time frame, there were 291 open posterior spine surgeries, two cases were excluded due to incomplete medical record, and therefore 289 cases were included in the analysis. Of these, seven (2.4%) patients were with SSI. Distribution of the age and gender of the patients with posterior spine surgeries and those with SSI are presented in Table 1. Most of the cases aged between 41-60 years and 58.13% cases were female. The most frequent spinal disorders in this study was spinal tuberculosis accounted for 88 cases (30.24%) followed by spinal stenosis (21.99%) (Table 2).

SSIs were occurred in seven patients: five patients with spinal tuberculosis, one patient each with scoliosis and spine fracture. Our analysis showed that only spinal tuberculosis was significantly associated with the risk of SSI [OR 95% CI=5.994 (1.140 - 31.515), p=0.034]. Other spinal disorders had no significant association with the risk of SSI (Table 2). Our analysis showed that spinal tuberculosis had 5.9 fold increased the risk of SSI compared with other spinal disorders.


DISCUSSION

SSI is a devastating complication in spine surgeries associated with various problems such as increased treatment costs, high morbidity, and some cases with mortality (4,13). In this study, we reported the incidence of SSI in spinal disorder treated with open posterior surgery and we tried to correlate between variables. This is the first study in Indonesia regarding SSI following spine surgery. The first study was reported by Turnbull in Canada (20).

Age is one of the individual risk factors in spinal disorder. Increasing age is directly proportional to increased risk of spinal disorders (21). Our result revealed that age 41-66 years was the commonest group with spinal disorders (Table 1). Previous studies found that the mean age for spinal disorder ranges from 44.2±16.0 to 63±14 years (5-8,10,12,14,16,18,22-32). This indicates that our result was consistent with previous findings. Although the prevalence of spinal disorders increase with age, a study showed that the relation between age and spinal disorders was not linear, suggesting that multiple factors are involved (33).

The incidence of SSI following spine surgery is varied depend on surgical procedure. Data revealed that the incidence ranges from 0.5% to 18.8% (34-39). Moreover, twenty studies reported were identified from PubMed and EMBASE regarding the incidence of SSI following spine surgery. They reported the incidence vary, ranging from 0.2% to 16.1% (5-8,10,12,14,16,18,22-32). Our result showed that the incidence of SSI following spine surgery was 2.4%. We tried to calculate the average of our result combined with the 20 studies, and the average was 4.7%. This indicates that our result was consistent with previous data. Interestingly, SSI incidence in our centre is lower than the average global incidence of SSI.

Of 289 spine surgeries, our analysis reveals that only spinal tuberculosis was associated with increased the risk of SSI. Our result was different with several studies. Studies found that trauma and or degenerative in cervical (8,18,27,28,32), thoracic (12), and lumbar spine (6,7,10) were the commonest cases associated with SSI. This difference could not be clearly explained. However, among those studies, spinal tuberculosis was not included because no case was identified. Perhaps if they included spinal tuberculosis, it is likely that the results would be similar to those in our study. Extra-pulmonary tuberculosis especially spinal tuberculosis is most common in human immunodeficiency virus-seropositive patients (40). However, in our country, high incidence and prevalence of pulmonary tuberculosis is logical to consider that extra-pulmonary tuberculosis should be relative high (41). All this time, there have been no study reported SSI on spinal tuberculosis. Therefore, we could not compare our results specifically. Nevertheless, it is well known that tuberculosis infection is one of the co-morbidities for SSI (27).

SSI by Mycobacterium tuberculosis is uncommon. However, several studies had reported M. tuberculosis associated SSI in patients with no history of tuberculosis (42-45). This indicated that the virulence of M. tuberculosisis very high. However, there may be other influential factors such as dormant, endemic areas, and others. In most cases, SSI by M. tuberculosis is caused by reactivation of dormant tuberculosis (46). In our study, spinal tuberculosis was the only case of infection. Therefore, the risk for SSI is higher in subjects with spinal tuberculosis than others. SSI by M. tuberculosis is an infection by M. tuberculosis in skin, soft tissue, and or organ (47). In the patients with an existing tuberculosis infection like in our study, SSI probably comes from primary sources. Influenced by several factors, it triggers to cause cutaneous and surgical wound infection.

Although the results of this study showed that spinal tuberculosis had the association with the increased risk of SSI. However, at present time, it is not possible to give recommendations for the use of specific management for spinal tuberculosis. Therefore, orthopedic organization
is expected to review SSI in spinal disorder especially spinal tuberculosis. Thus, there would be the gold standard recommendations for the use of specific management
to prevent SSI as recommended by World Health Organization (3).

This study had several limitations. First, in this study was not included data regarding the risk factors associated with SSI, i.e. intra-operative blood loss, operative time, inpatient stay prior to index operation, smoking, alcohol abuse, malnutrition, diabetes, and long-term steroid use like described by Olsen et al. (5). Second, false negative results could be occurred in this study due to the small sample size. Therefore, further studies with a larger sample size are required to determine the better association. Third, we did not evaluate the post-operative outcome. Fourth, we did not identify the microbial agent causing the SSIs. Lastly, this was retrospective study and therefore further study with cohort design is needed.


CONCLUSION

Spinal tuberculosis is indicated to be correlated with the risk of SSI. In addition, the study also showed that spinal tuberculosis is a case to be aware because it is potentially to trigger SSI.


Ethics Committee Approval: Our study was approved by the Institutional Review Board of Syiah Kuala University (no: 017/KE/FK/2015), and carried out in accordance with The Declaration of Helsinki.

Informed Consent: Because this was a retrospective study, the signed written informed consent was not required.

Authorship Contributions

Surgical and Medical Practices: A.A., Concept: A.A., J.K.F., Design: A.A., H.H., J.K.F., Data Collection or Processing: H.H., Analysis or Interpretation: H.H., Literature Search: H.H., J.K.F., Writing: A.A., H.H., J.K.F.

Conflict of Interest: No conflict of interest was declared by the authors.

Financial Disclosure: The authors declared that this study received no financial support.

Images

  1. Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR. Guideline for Prevention of Surgical Site Infection, 1999. Centers for Disease Control and Prevention (CDC) Hospital Infection Control Practices Advisory Committee. Am J Infect Control 1999;27:97-132; quiz 133-4; discussion 96.
  2. Owens CD, Stoessel K. Surgical site infections: epidemiology, microbiology and prevention. J Hosp Infect 2008;70:3-10.
  3. WHO. Global Guidelines for the Prevention of Surgical Site Infection. Geneva: WHO Library Cataloguing-in-Publication Data; 2016.
  4. Reichman DE, Greenberg JA. Reducing surgical site infections: a review. Rev Obstet Gynecol 2009;2:212-21.
  5. Olsen MA, Mayfield J, Lauryssen C, Polish LB, Jones M, Vest J, et al. Risk factors for surgical site infection in spinal surgery. J Neurosurg 2003;98:149-55.
  6. Pull ter Gunne AF, Cohen DB. Incidence, prevalence, and analysis of risk factors for surgical site infection following adult spinal surgery. Spine 2009;34:1422-8.
  7. O’Toole JE, Eichholz KM, Fessler RG. Surgical site infection rates after minimally invasive spinal surgery. J Neurosurg Spine 2009;11:471-6.
  8. Blam OG, Vaccaro AR, Vanichkachorn JS, Albert TJ, Hilibrand AS, Minnich JM, et al. Risk Factors for Surgical Site Infection in the Patient With Spinal Injury. Spine 2003;28:1475-80.
  9. Linam WM, Margolis PA, Staat MA, Britto MT, Hornung R, Cassedy A, et al. Risk factors associated with surgical site infection after pediatric posterior spinal fusion procedure. Infect Control Hosp Epidemiol 2009;30:109-16.
  10. Watanabe M, Sakai D, Matsuyama D, Yamamoto Y, Sato M, Mochida J. Risk factors for surgical site infection following spine surgery: efficacy of intraoperative saline irrigation. J Neurosurg Spine 2010;12:540-6.
  11. Calderone RR, Garland DE, Capen DA, Oster H. Cost of medical care for postoperative spinal infections. Orthop Clin North Am 1996;27:171-82.
  12. Abdul-Jabbar A, Berven SH, Hu SS, Chou D, Mummaneni PV, Takemoto S, et al. Surgical Site Infections in Spine Surgery. Spine 2013;38:E1425-E31.
  13. Mekontso-Dessap A, Kirsch M, Brun-Buisson C, Loisance D. Poststernotomy mediastinitis due to Staphylococcus aureus: comparison of methicillin-resistant and methicillin-susceptible cases. Clin Infect Dis 2001;32:877-83.
  14. Kirkland KB, Briggs JP, Trivette SL, Wilkinson WE, Sexton DJ. The impact of surgical-site infections in the 1990s: attributable mortality, excess length of hospitalization, and extra costs. Infect Control Hosp Epidemiol 1999;20:725-30.
  15. McGarry SA, Engemann JJ, Schmader K, Sexton DJ, Kaye KS. Surgical-site infection due to Staphylococcus aureus among elderly patients: mortality, duration of hospitalization, and cost. Infect Control Hosp Epidemiol 2004;25:461-7.
  16. Klemencsics I, Lazary A, Szoverfi Z, Bozsodi A, Eltes P, Varga PP. Risk factors for surgical site infection in elective routine degenerative lumbar surgeries. Spine J 2016;16:1377-83.
  17. Acklin YP, Widmer AF, Renner RM, Frei R, Gross T. Unexpectedly increased rate of surgical site infections following implant surgery for hip fractures: problem solution with the bundle approach. Injury 2011;42:209-16.
  18. Cooper K, Glenn CA, Martin M, Stoner J, Li J, Puckett T. Risk factors for surgical site infection after instrumented fixation in spine trauma. J Clinical Neurosci 2016;23:123-27.
  19. Berkow L, Rotolo S, Mirski E. Continuous noninvasive hemoglobin monitoring during complex spine surgery. Anesth Analg 2011;113:1396-402.
  20. Turnbull F. Postoperative inflammatory disease of lumbar discs. J Neurosurg 1953;10:469-73.
  21. Burdorf A, Sorock G. Positive and negative evidence of risk factors for back disorders. Scand J Work Environ Health 1997;23:243-56.
  22. Malone DL, Genuit T, Tracy JK, Gannon C, Napolitano LM. Surgical site infections: reanalysis of risk factors. J Surg Res 2002;103:89-95.
  23. Kanayama M, Hashimoto T, Shigenobu K, Oha F, Togawa D. Effective prevention of surgical site infection using a Centers for Disease Control and Prevention guideline-based antimicrobial prophylaxis in lumbar spine surgery. J Neurosurg Spine 2007;6:327-9.
  24. Rao SB, Vasquez G, Harrop J, Maltenfort M, Stein N, Kaliyadan G, et al. Risk factors for surgical site infections following spinal fusion procedures: a case-control study. Clin Infect Dis 2011;53:686-92.
  25. Lee MJ, Cizik AM, Hamilton D, Chapman JR. Predicting surgical site infection after spine surgery: a validated model using a prospective surgical registry. Spine J 2014;14:2112-7.
  26. Atkinson RA, Davies B, Jones A, van Popta D, Ousey K, Stephenson J. Survival of patients undergoing surgery for metastatic spinal tumours and the impact of surgical site infection. J Hospital Infect 2016;94:80-5.
  27. Ojo OA, Owolabi BS, Oseni AW, Kanu OO, Bankole OB. Surgical site infection in posterior spine surgery. Niger J Clin Pract 2016;19:821-6.
  28. Sebastian A, Huddleston P, Kakar S, Habermann E, Wagie A, Nassr A. Risk factors for surgical site infection after posterior cervical spine surgery: an analysis of 5,441 patients from the ACS NSQIP 2005-2012. Spine J 2016;16:504-9.
  29. Thakkar V, Ghobrial GM, Maulucci CM, Singhal S, Prasad SK, Harrop JS, et al. Nasal MRSA colonization: impact on surgical site infection following spine surgery. Clin Neurol Neurosurg 2014;125:94-7.
  30. Atkinson RA, Jones A, Ousey K, Stephenson J. Management and cost of surgical site infection in patients undergoing surgery for spinal metastasis. J Hospital Infect 2017; 95:148-53.
  31. Iwakiri K, Kobayashi A, Seki M, Ando Y, Tsujio T, Hoshino M, et al. Waterless hand rub versus traditional hand scrub methods for preventing the surgical-site infection in orthopaedic surgery. Spine (Phila Pa 1976) 2017;42:1675-9.
  32. Dessy AM, Yuk FJ, Maniya AY, Connolly JG, Nathanson JT, Rasouli JJ, et al. Reduced Surgical Site Infection Rates Following Spine Surgery Using an Enhanced Prophylaxis Protocol. Cureus 2017;9:e1139.
  33. Manek NJ, MacGregor AJ. Epidemiology of back disorders: prevalence, risk factors, and prognosis. Curr Opin Rheumatol 2005;17:134-40.
  34. Chahoud J, Kanafani Z, Kanj SS. Surgical site infections following spine surgery: eliminating the controversies in the diagnosis. Front Med (Lausanne) 2014;24:1-7.
  35. Khan NR, Thompson CJ, Decuypere M, Angotti JM, Kalobwe E, Muhlbauer MS, et al. A meta-analysis of spinal surgical site infection and vancomycin powder. J Neurosurg Spine 2014;21:974-83.
  36. Boody BS, Jenkins TJ, Hashmi SZ, Hsu WK, Patel AA, Savage JW. Surgical Site Infections in Spinal Surgery. J Spinal Disord Tech 2015;28:352-62.
  37. Meng F, Cao J, Meng X. Risk factors for surgical site infections following spinal surgery. J Clin Neurosci 2015;22:1862-6.
  38. Floccari LV, Milbrandt TA. Surgical site infections after pediatric spine surgery. Orthop Clin N Am 2016;47:387-94.
  39. Haddad S, Millhouse PW, Maltenfort M, Restrepo C, Kepler CK, Vaccaro AR. Diagnosis and neurologic status as predictors of surgical site infection in primary cervical spinal surgery. Spine J 2016;16:632-42.
  40. Singh S, Pandey D, Ahmad Z, Bhargava R, Hameed I, Mehfooz N. Unusual presentation of tuberculosis. Trop Doct 2009;39:183-4.
  41. WHO. Global tuberculosis report 2015 20th edition. Geneva: WHO Library Cataloguing-in-Publication Data; 2015.
  42. Spinner RJ, Sexton DJ, Goldner RD, Levin LS. Periprosthetic infections due to Mycobacterium tuberculosis in patients with no prior history of tuberculosis. J Arthroplasty 1996;11:217-22.
  43. Kestler M, Reves R, Belknap R. Pacemaker wire infection with Mycobacterium tuberculosis: a case report and literature review. Int J Tuberc Lung Dis 2009;13:272-4.
  44. Salam MA, Asafudullah SM, Huda MN, Akhter N, Islam AMM. Surgical site infection by Mycobacterium tuberculosis following caesarian section. Pak J Med Sci 2011;27:945-7.
  45. Mazid MA, Rahim MM, Rahman MM, Sultana N. Delayed Surgical Site Infection by Tuberculosis – A Rising Cause of Concern? J Bangladesh Coll Phys Surg 2014;32:186-9.
  46. Derkash RS, Makley JT. Isolated tuberculosis of the triceps muscle: Case report. J Bone Joint Surg Am 1979;61:948.
  47. Dutt AK, Stead WW. Epidemiology In: Schlossberg D, editor. Tuberculosis and nontuberculous mycobacterial infection. Philadelphia: W.B. Saunders Company; 1999.